{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:20:46Z","timestamp":1792272046257,"version":"4.4.0"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,11,23]],"date-time":"2010-11-23T00:00:00Z","timestamp":1290470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00415-010-5836-5","type":"journal-article","created":{"date-parts":[[2010,11,22]],"date-time":"2010-11-22T22:14:46Z","timestamp":1290464086000},"page":"533-548","source":"Crossref","is-referenced-by-count":86,"title":["The role of cytokines in Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"258","author":[{"given":"Ming-Ou","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,23]]},"reference":[{"key":"5836_CR1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","volume":"7","author":"PA Doorn van","year":"2008","unstructured":"van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain\u2013Barre syndrome. Lancet Neurol 7:939\u2013950","journal-title":"Lancet Neurol"},{"issue":"Pt 3","key":"5836_CR2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","volume":"118","author":"JW Griffin","year":"1995","unstructured":"Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, Yang C, Tian M, Mishu B, Cornblath DR (1995) Guillain\u2013Barre syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118(Pt 3):577\u2013595","journal-title":"Brain"},{"key":"5836_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","volume":"255","author":"M Fisher","year":"1956","unstructured":"Fisher M (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255:57\u201365","journal-title":"N Engl J Med"},{"key":"5836_CR4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20762","volume":"35","author":"N Yuki","year":"2007","unstructured":"Yuki N (2007) Ganglioside mimicry and peripheral nerve disease. Muscle Nerve 35:691\u2013711","journal-title":"Muscle Nerve"},{"key":"5836_CR5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","volume":"16","author":"S Vucic","year":"2009","unstructured":"Vucic S, Kiernan MC, Cornblath DR (2009) Guillain\u2013Barre syndrome: an update. J Clin Neurosci 16:733\u2013741","journal-title":"J Clin Neurosci"},{"key":"5836_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","volume":"100","author":"RA Hughes","year":"1999","unstructured":"Hughes RA, Hadden RD, Gregson NA, Smith KJ (1999) Pathogenesis of Guillain\u2013Barre syndrome. J Neuroimmunol 100:74\u201397","journal-title":"J Neuroimmunol"},{"key":"5836_CR7","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","volume":"125","author":"HJ Willison","year":"2002","unstructured":"Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591\u20132625","journal-title":"Brain"},{"key":"5836_CR8","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA (2007) Immunotherapy for Guillain\u2013Barre syndrome: a systematic review. Brain 130:2245\u20132257","journal-title":"Brain"},{"key":"5836_CR9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","volume":"352","author":"AF Hahn","year":"1998","unstructured":"Hahn AF (1998) Guillain\u2013Barre syndrome. Lancet 352:635\u2013641","journal-title":"Lancet"},{"key":"5836_CR10","doi-asserted-by":"crossref","unstructured":"Hughes RA, Swan AV, van Koningsveld R, van Doorn PA (2006) Corticosteroids for Guillain\u2013Barre syndrome. Cochrane Database Syst Rev: CD001446","DOI":"10.1002\/14651858.CD001446.pub2"},{"key":"5836_CR11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","volume":"326","author":"FG Meche van der","year":"1992","unstructured":"van der Meche FG, Schmitz PI (1992) A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barre syndrome. Dutch Guillain\u2013Barre Study Group. N Engl J Med 326:1123\u20131129","journal-title":"N Engl J Med"},{"key":"5836_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","volume":"84","author":"J Zhu","year":"1998","unstructured":"Zhu J, Mix E, Link H (1998) Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain\u2013Barre syndrome. J Neuroimmunol 84:40\u201352","journal-title":"J Neuroimmunol"},{"key":"5836_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/clin.1997.4356","volume":"84","author":"J Zhu","year":"1997","unstructured":"Zhu J, Bai XF, Mix E, Link H (1997) Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin Immunol Immunopathol 84:85\u201394","journal-title":"Clin Immunol Immunopathol"},{"key":"5836_CR14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jnen\/61.7.614","volume":"61","author":"S Yu","year":"2002","unstructured":"Yu S, Chen Z, Mix E, Zhu SW, Winblad B, Ljunggren HG, Zhu J (2002) Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen. J Neuropathol Exp Neurol 61:614\u2013622","journal-title":"J Neuropathol Exp Neurol"},{"key":"5836_CR15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jneuroim.2005.07.019","volume":"168","author":"F Nicoletti","year":"2005","unstructured":"Nicoletti F, Creange A, Orlikowski D, Bolgert F, Mangano K, Metz C, Di Marco R, Al Abed Y (2005) Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain\u2013Barre syndrome and experimental allergic neuritis. J Neuroimmunol 168:168\u2013174","journal-title":"J Neuroimmunol"},{"key":"5836_CR16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1750-3639.2002.tb00459.x","volume":"12","author":"L Bao","year":"2002","unstructured":"Bao L, Lindgren JU, van der Meide P, Zhu S, Ljunggren HG, Zhu J (2002) The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis. Brain Pathol 12:420\u2013429","journal-title":"Brain Pathol"},{"key":"5836_CR17","first-page":"211","volume":"148","author":"R Kiefer","year":"1996","unstructured":"Kiefer R, Funa K, Schweitzer T, Jung S, Bourde O, Toyka KV, Hartung HP (1996) Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course. Am J Pathol 148:211\u2013223","journal-title":"Am J Pathol"},{"key":"5836_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2567.1999.00749.x","volume":"97","author":"G Deretzi","year":"1999","unstructured":"Deretzi G, Pelidou S, Zou L, Quiding C, Mix E, Levi M, Wahren B, Zhu J (1999) Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6. Immunology 97:69\u201376","journal-title":"Immunology"},{"key":"5836_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/clin.1997.4331","volume":"83","author":"XF Bai","year":"1997","unstructured":"Bai XF, Zhu J, Zhang GX, Kaponides G, Hojeberg B, van der Meide PH, Link H (1997) IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clin Immunol Immunopathol 83:117\u2013126","journal-title":"Clin Immunol Immunopathol"},{"key":"5836_CR20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","volume":"26","author":"MO Li","year":"2007","unstructured":"Li MO, Wan YY, Flavell RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579\u2013591","journal-title":"Immunity"},{"key":"5836_CR21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.immuni.2007.05.003","volume":"26","author":"MJ McGeachy","year":"2007","unstructured":"McGeachy MJ, Cua DJ (2007) T cells doing it for themselves: TGF-beta regulation of Th1 and Th17 cells. Immunity 26:547\u2013549","journal-title":"Immunity"},{"key":"5836_CR22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","volume":"15","author":"J Harness","year":"2008","unstructured":"Harness J, McCombe PA (2008) Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain\u2013Barre syndrome patients compared to controls. J Clin Neurosci 15:1031\u20131035","journal-title":"J Clin Neurosci"},{"key":"5836_CR23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2007.09.034","volume":"192","author":"LJ Chi","year":"2007","unstructured":"Chi LJ, Wang HB, Zhang Y, Wang WZ (2007) Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain\u2013Barre syndrome. J Neuroimmunol 192:206\u2013214","journal-title":"J Neuroimmunol"},{"issue":"Pt 6","key":"5836_CR24","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/115.6.1633","volume":"115","author":"B Schmidt","year":"1992","unstructured":"Schmidt B, Stoll G, van der Meide P, Jung S, Hartung HP (1992) Transient cellular expression of gamma-interferon in myelin-induced and T-cell line-mediated experimental autoimmune neuritis. Brain 115(Pt 6):1633\u20131646","journal-title":"Brain"},{"key":"5836_CR25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/08916930701356846","volume":"40","author":"I Girkontaite","year":"2007","unstructured":"Girkontaite I, Urbonaviciute V, Maseda D, Neubert K, Herrmann M, Voll RE (2007) Apoptotic cells selectively suppress the Th1 cytokine interferon gamma in stimulated human peripheral blood mononuclear cells and shift the Th1\/Th2 balance towards Th2. Autoimmunity 40:327\u2013330","journal-title":"Autoimmunity"},{"key":"5836_CR26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/cimm.1996.0050","volume":"168","author":"R Gold","year":"1996","unstructured":"Gold R, Zielasek J, Kiefer R, Toyka KV, Hartung HP (1996) Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. Cell Immunol 168:69\u201377","journal-title":"Cell Immunol"},{"key":"5836_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/cimm.1995.1187","volume":"165","author":"R Gold","year":"1995","unstructured":"Gold R, Toyka KV, Hartung HP (1995) Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 165:65\u201370","journal-title":"Cell Immunol"},{"key":"5836_CR28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1006\/exnr.2001.7662","volume":"169","author":"Y Zhu","year":"2001","unstructured":"Zhu Y, Ljunggren HG, Mix E, Li HL, van der Meide P, Elhassan AM, Winblad B, Zhu J (2001) Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice. Exp Neurol 169:472\u2013478","journal-title":"Exp Neurol"},{"key":"5836_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-5728(98)00053-8","volume":"87","author":"K Hohnoki","year":"1998","unstructured":"Hohnoki K, Inoue A, Koh CS (1998) Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha\/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. J Neuroimmunol 87:27\u201332","journal-title":"J Neuroimmunol"},{"key":"5836_CR30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jocn.2004.04.006","volume":"12","author":"PA Csurhes","year":"2005","unstructured":"Csurhes PA, Sullivan AA, Green K, Greer JM, Pender MP, McCombe PA (2005) Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain\u2013Barre syndrome. J Clin Neurosci 12:409\u2013415","journal-title":"J Clin Neurosci"},{"key":"5836_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/clin.1998.4573","volume":"88","author":"RA Elkarim","year":"1998","unstructured":"Elkarim RA, Dahle C, Mustafa M, Press R, Zou LP, Ekerfelt C, Ernerudh J, Link H, Bakhiet M (1998) Recovery from Guillain\u2013Barre syndrome is associated with increased levels of neutralizing autoantibodies to interferon-gamma. Clin Immunol Immunopathol 88:241\u2013248","journal-title":"Clin Immunol Immunopathol"},{"key":"5836_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.192.1.123","volume":"192","author":"CQ Chu","year":"2000","unstructured":"Chu CQ, Wittmer S, Dalton DK (2000) Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 192:123\u2013128","journal-title":"J Exp Med"},{"key":"5836_CR33","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.4049\/jimmunol.158.12.5997","volume":"158","author":"LS Jones","year":"1997","unstructured":"Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert B, Caspi RR (1997) IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol 158:5997\u20136005","journal-title":"J Immunol"},{"key":"5836_CR34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1189\/jlb.0806486","volume":"81","author":"H Kelchtermans","year":"2007","unstructured":"Kelchtermans H, Struyf S, De Klerck B, Mitera T, Alen M, Geboes L, Van Balen M, Dillen C, Put W, Gysemans C, Billiau A, Van Damme J, Matthys P (2007) Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production. J Leukoc Biol 81:1044\u20131053","journal-title":"J Leukoc Biol"},{"key":"5836_CR35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diabetes.47.1.32","volume":"47","author":"F Nicoletti","year":"1998","unstructured":"Nicoletti F, Zaccone P, Di Marco R, Magro G, Grasso S, Stivala F, Calori G, Mughini L, Meroni PL, Garotta G (1998) Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats. Diabetes 47:32\u201338","journal-title":"Diabetes"},{"key":"5836_CR36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/CDLI.4.6.764-768.1997","volume":"4","author":"DO Sobel","year":"1997","unstructured":"Sobel DO, Newsome J (1997) Gamma interferon prevents diabetes in the BB rat. Clin Diagn Lab Immunol 4:764\u2013768","journal-title":"Clin Diagn Lab Immunol"},{"key":"5836_CR37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/jaut.2002.0604","volume":"19","author":"DO Sobel","year":"2002","unstructured":"Sobel DO, Han J, Williams J, Yoon JW, Jun HS, Ahvazi B (2002) Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse. J Autoimmun 19:129\u2013137","journal-title":"J Autoimmun"},{"key":"5836_CR38","doi-asserted-by":"crossref","unstructured":"(1992) Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis. German Lymphokine Study Group. Rheumatol Int 12:175\u2013185","DOI":"10.1007\/BF00302149"},{"key":"5836_CR39","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/ard.51.9.1039","volume":"51","author":"KP Machold","year":"1992","unstructured":"Machold KP, Neumann K, Smolen JS (1992) Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study. Ann Rheum Dis 51:1039\u20131043","journal-title":"Ann Rheum Dis"},{"key":"5836_CR40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/030097401316909530","volume":"30","author":"YA Sigidin","year":"2001","unstructured":"Sigidin YA, Loukina GV, Skurkovich B, Skurkovich S (2001) Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis. Scand J Rheumatol 30:203\u2013207","journal-title":"Scand J Rheumatol"},{"key":"5836_CR41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","volume":"29","author":"H Kelchtermans","year":"2008","unstructured":"Kelchtermans H, Billiau A, Matthys P (2008) How interferon-gamma keeps autoimmune diseases in check. Trends Immunol 29:479\u2013486","journal-title":"Trends Immunol"},{"key":"5836_CR42","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1167\/iovs.07-0233","volume":"48","author":"SB Su","year":"2007","unstructured":"Su SB, Grajewski RS, Luger D, Agarwal RK, Silver PB, Tang J, Tuo J, Chan CC, Caspi RR (2007) Altered chemokine profile associated with exacerbated autoimmune pathology under conditions of genetic interferon-gamma deficiency. Invest Ophthalmol Vis Sci 48:4616\u20134625","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5836_CR43","first-page":"2434","volume":"116","author":"Z Wang","year":"2006","unstructured":"Wang Z, Hong J, Sun W, Xu G, Li N, Chen X, Liu A, Xu L, Sun B, Zhang JZ (2006) Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25\u2212 T cells to CD4+ Tregs. J Clin Invest 116:2434\u20132441","journal-title":"J Clin Invest"},{"key":"5836_CR44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","volume":"205","author":"D Luger","year":"2008","unstructured":"Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205:799\u2013810","journal-title":"J Exp Med"},{"key":"5836_CR45","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar2787","volume":"11","author":"H Kelchtermans","year":"2009","unstructured":"Kelchtermans H, Schurgers E, Geboes L, Mitera T, Van Damme J, Van Snick J, Uyttenhove C, Matthys P (2009) Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res Ther 11:R122","journal-title":"Arthritis Res Ther"},{"key":"5836_CR46","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1471-4159.2004.02954.x","volume":"92","author":"I Shaked","year":"2005","unstructured":"Shaked I, Tchoresh D, Gersner R, Meiri G, Mordechai S, Xiao X, Hart RP, Schwartz M (2005) Protective autoimmunity: interferon-gamma enables microglia to remove glutamate without evoking inflammatory mediators. J Neurochem 92:997\u20131009","journal-title":"J Neurochem"},{"key":"5836_CR47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11481-005-9010-2","volume":"1","author":"M Schwartz","year":"2006","unstructured":"Schwartz M, Butovsky O, Kipnis J (2006) Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy. J Neuroimmune Pharmacol 1:4\u201310","journal-title":"J Neuroimmune Pharmacol"},{"key":"5836_CR48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2003.10.049","volume":"146","author":"I Shaked","year":"2004","unstructured":"Shaked I, Porat Z, Gersner R, Kipnis J, Schwartz M (2004) Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system. J Neuroimmunol 146:84\u201393","journal-title":"J Neuroimmunol"},{"key":"5836_CR49","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4049\/jimmunol.180.2.842","volume":"180","author":"KE Foulds","year":"2008","unstructured":"Foulds KE, Rotte MJ, Paley MA, Singh B, Douek DC, Hill BJ, O\u2019Shea JJ, Watford WT, Seder RA, Wu CY (2008) IFN-gamma mediates the death of Th1 cells in a paracrine manner. J Immunol 180:842\u2013849","journal-title":"J Immunol"},{"key":"5836_CR50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jneuroim.2009.10.001","volume":"217","author":"S Huang","year":"2009","unstructured":"Huang S, Li L, Liang S, Wang W (2009) Conversion of peripheral CD4(+)CD25(\u2212) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain\u2013Barre syndrome. J Neuroimmunol 217:80\u201384","journal-title":"J Neuroimmunol"},{"key":"5836_CR51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0165-5728(96)00131-2","volume":"71","author":"R Murwani","year":"1996","unstructured":"Murwani R, Hodgkinson S, Armati P (1996) Tumor necrosis factor alpha and interleukin-6 mRNA expression in neonatal Lewis rat Schwann cells and a neonatal rat Schwann cell line following interferon gamma stimulation. J Neuroimmunol 71:65\u201371","journal-title":"J Neuroimmunol"},{"key":"5836_CR52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0969-9961(02)00007-4","volume":"12","author":"L Bao","year":"2003","unstructured":"Bao L, Lindgren JU, Zhu Y, Ljunggren HG, Zhu J (2003) Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis. Neurobiol Dis 12:73\u201381","journal-title":"Neurobiol Dis"},{"key":"5836_CR53","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(94)90372-7","volume":"76","author":"CA Smith","year":"1994","unstructured":"Smith CA, Farrah T, Goodwin RG (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959\u2013962","journal-title":"Cell"},{"key":"5836_CR54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.mcn.2005.10.011","volume":"31","author":"VI Shubayev","year":"2006","unstructured":"Shubayev VI, Angert M, Dolkas J, Campana WM, Palenscar K, Myers RR (2006) TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci 31:407\u2013415","journal-title":"Mol Cell Neurosci"},{"key":"5836_CR55","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10571-007-9215-4","volume":"27","author":"C Cheng","year":"2007","unstructured":"Cheng C, Qin Y, Shao X, Wang H, Gao Y, Cheng M, Shen A (2007) Induction of TNF-alpha by LPS in Schwann cell is regulated by MAPK activation signals. Cell Mol Neurobiol 27:909\u2013921","journal-title":"Cell Mol Neurobiol"},{"key":"5836_CR56","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0014-4886(03)00297-8","volume":"184","author":"RR Myers","year":"2003","unstructured":"Myers RR, Sekiguchi Y, Kikuchi S, Scott B, Medicherla S, Protter A, Campana WM (2003) Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp Neurol 184:606\u2013614","journal-title":"Exp Neurol"},{"key":"5836_CR57","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.nbd.2005.03.022","volume":"20","author":"K Boyle","year":"2005","unstructured":"Boyle K, Azari MF, Cheema SS, Petratos S (2005) TNFalpha mediates Schwann cell death by upregulating p75NTR expression without sustained activation of NFkappaB. Neurobiol Dis 20:412\u2013427","journal-title":"Neurobiol Dis"},{"key":"5836_CR58","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1471-4159.2009.06346.x","volume":"111","author":"T Tao","year":"2009","unstructured":"Tao T, Ji Y, Cheng C, Yang H, Liu H, Sun L, Qin Y, Yang J, Wang H, Shen A (2009) Tumor necrosis factor-alpha inhibits Schwann cell proliferation by up-regulating Src-suppressed protein kinase C substrate expression. J Neurochem 111:647\u2013655","journal-title":"J Neurochem"},{"key":"5836_CR59","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/icb.2010.12","volume":"88","author":"M Evangelidou","year":"2010","unstructured":"Evangelidou M, Tseveleki V, Vamvakas SS, Probert L (2010) TNFRI is a positive T-cell costimulatory molecule important for the timing of cytokine responses. Immunol Cell Biol 88:586\u2013595","journal-title":"Immunol Cell Biol"},{"key":"5836_CR60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0404.2003.00179.x","volume":"109","author":"VV Radhakrishnan","year":"2004","unstructured":"Radhakrishnan VV, Sumi MG, Reuben S, Mathai A, Nair MD (2004) Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain\u2013Barre syndrome. Acta Neurol Scand 109:71\u201374","journal-title":"Acta Neurol Scand"},{"key":"5836_CR61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000102162","volume":"58","author":"J Zhang","year":"2007","unstructured":"Zhang J, Dong H, Li B, Li CY, Guo L (2007) Association of tumor necrosis factor polymorphisms with Guillain\u2013Barre syndrome. Eur Neurol 58:21\u201325","journal-title":"Eur Neurol"},{"key":"5836_CR62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1085-9489.2005.10309.x","volume":"10","author":"M Kurz","year":"2005","unstructured":"Kurz M, Pischel H, Hartung HP, Kieseier BC (2005) Tumor necrosis factor-alpha-converting enzyme is expressed in the inflamed peripheral nervous system. J Peripher Nerv Syst 10:311\u2013318","journal-title":"J Peripher Nerv Syst"},{"key":"5836_CR63","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1212\/WNL.52.9.1833","volume":"52","author":"MK Sharief","year":"1999","unstructured":"Sharief MK, Ingram DA, Swash M, Thompson EJ (1999) I.v. immunoglobulin reduces circulating proinflammatory cytokines in Guillain\u2013Barre syndrome. Neurology 52:1833\u20131838","journal-title":"Neurology"},{"key":"5836_CR64","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1468-1331.2008.02261.x","volume":"15","author":"H Deng","year":"2008","unstructured":"Deng H, Yang X, Jin T, Wu J, Hu LS, Chang M, Sun XJ, Adem A, Winblad B, Zhu J (2008) The role of IL-12 and TNF-alpha in AIDP and AMAN. Eur J Neurol 15:1100\u20131105","journal-title":"Eur J Neurol"},{"key":"5836_CR65","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/eji.1830250521","volume":"25","author":"V Ruiz de Souza","year":"1995","unstructured":"Ruiz de Souza V, Carreno MP, Kaveri SV, Ledur A, Sadeghi H, Cavaillon JM, Kazatchkine MD, Haeffner-Cavaillon N (1995) Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol 25:1267\u20131273","journal-title":"Eur J Immunol"},{"key":"5836_CR66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2009.12.045","volume":"470","author":"XJ Mao","year":"2010","unstructured":"Mao XJ, Zhang XM, Zhang HL, Quezada HC, Mix E, Yang X, Winblad B, Adem A, Zhu J (2010) TNF-alpha receptor 1 deficiency reduces antigen-presenting capacity of Schwann cells and ameliorates experimental autoimmune neuritis in mice. Neurosci Lett 470:19\u201323","journal-title":"Neurosci Lett"},{"key":"5836_CR67","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2006.11.027","volume":"183","author":"JM Taylor","year":"2007","unstructured":"Taylor JM, Pollard JD (2007) Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation. J Neuroimmunol 183:118\u2013124","journal-title":"J Neuroimmunol"},{"key":"5836_CR68","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bbi.2006.12.008","volume":"21","author":"WM Campana","year":"2007","unstructured":"Campana WM (2007) Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav Immun 21:522\u2013527","journal-title":"Brain Behav Immun"},{"key":"5836_CR69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbi.2006.07.007","volume":"21","author":"G Moalem-Taylor","year":"2007","unstructured":"Moalem-Taylor G, Allbutt HN, Iordanova MD, Tracey DJ (2007) Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy. Brain Behav Immun 21:699\u2013710","journal-title":"Brain Behav Immun"},{"key":"5836_CR70","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1460-9568.2006.04606.x","volume":"23","author":"WM Campana","year":"2006","unstructured":"Campana WM, Li X, Shubayev VI, Angert M, Cai K, Myers RR (2006) Erythropoietin reduces Schwann cell TNF-alpha, Wallerian degeneration and pain-related behaviors after peripheral nerve injury. Eur J Neurosci 23:617\u2013626","journal-title":"Eur J Neurosci"},{"key":"5836_CR71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0165-5728(96)00075-6","volume":"68","author":"A Creange","year":"1996","unstructured":"Creange A, Belec L, Clair B, Raphael JC, Gherardi RK (1996) Circulating tumor necrosis factor (TNF)-alpha and soluble TNF-alpha receptors in patients with Guillain\u2013Barre syndrome. J Neuroimmunol 68:95\u201399","journal-title":"J Neuroimmunol"},{"key":"5836_CR72","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnen\/59.5.368","volume":"59","author":"A Weishaupt","year":"2000","unstructured":"Weishaupt A, Gold R, Hartung T, Gaupp S, Wendel A, Bruck W, Toyka KV (2000) Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis. J Neuropathol Exp Neurol 59:368\u2013376","journal-title":"J Neuropathol Exp Neurol"},{"key":"5836_CR73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2007.02.004","volume":"186","author":"MO Lu","year":"2007","unstructured":"Lu MO, Duan RS, Quezada HC, Chen ZG, Mix E, Jin T, Yang X, Ljunggren HG, Zhu J (2007) Aggravation of experimental autoimmune neuritis in TNF-alpha receptor 1 deficient mice. J Neuroimmunol 186:19\u201326","journal-title":"J Neuroimmunol"},{"key":"5836_CR74","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jnr.21600","volume":"86","author":"MO Lu","year":"2008","unstructured":"Lu MO, Zhang XM, Mix E, Quezada HC, Jin T, Zhu J, Adem A (2008) TNF-alpha receptor 1 deficiency enhances kainic acid-induced hippocampal injury in mice. J Neurosci Res 86:1608\u20131614","journal-title":"J Neurosci Res"},{"key":"5836_CR75","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.47.6.1531","volume":"47","author":"BW Oosten van","year":"1996","unstructured":"van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH (1996) Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47:1531\u20131534","journal-title":"Neurology"},{"key":"5836_CR76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","volume":"179","author":"X Chen","year":"2007","unstructured":"Chen X, Baumel M, Mannel DN, Howard OM, Oppenheim JJ (2007) Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol 179:154\u2013161","journal-title":"J Immunol"},{"key":"5836_CR77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000289201","volume":"11","author":"X Chen","year":"2010","unstructured":"Chen X, Oppenheim JJ (2010) TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr Dir Autoimmun 11:119\u2013134","journal-title":"Curr Dir Autoimmun"},{"key":"5836_CR78","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.0902070","volume":"184","author":"M Nagar","year":"2010","unstructured":"Nagar M, Jacob-Hirsch J, Vernitsky H, Berkun Y, Ben-Horin S, Amariglio N, Bank I, Kloog Y, Rechavi G, Goldstein I (2010) TNF activates a NF-kappaB-regulated cellular program in human CD45RA-regulatory T cells that modulates their suppressive function. J Immunol 184:3570\u20133581","journal-title":"J Immunol"},{"key":"5836_CR79","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1158\/1078-0432.CCR-07-0776","volume":"13","author":"M Del Vecchio","year":"2007","unstructured":"Del Vecchio M, Bajetta E, Canova S, Lotze MT, Wesa A, Parmiani G, Anichini A (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13:4677\u20134685","journal-title":"Clin Cancer Res"},{"key":"5836_CR80","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.0800276","volume":"183","author":"S Brahmachari","year":"2009","unstructured":"Brahmachari S, Pahan K (2009) Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 183:2045\u20132058","journal-title":"J Immunol"},{"key":"5836_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(00)00249-6","volume":"107","author":"DM Calida","year":"2000","unstructured":"Calida DM, Kremlev SG, Fujioka T, Hilliard B, Ventura E, Constantinescu CS, Lavi E, Rostami A (2000) Experimental allergic neuritis in the SJL\/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12. J Neuroimmunol 107:1\u20137","journal-title":"J Neuroimmunol"},{"key":"5836_CR82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1365-3083.2000.00636.x","volume":"51","author":"SH Pelidou","year":"2000","unstructured":"Pelidou SH, Zou LP, Deretzi G, Nennesmo I, Wei L, Mix E, Van Der Meide PH, Zhu J (2000) Intranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis rats. Scand J Immunol 51:29\u201335","journal-title":"Scand J Immunol"},{"key":"5836_CR83","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1212\/WNL.58.3.476","volume":"58","author":"R Press","year":"2002","unstructured":"Press R, Ozenci V, Kouwenhoven M, Link H (2002) Non-T(H)1 cytokines are augmented systematically early in Guillain\u2013Barre syndrome. Neurology 58:476\u2013478","journal-title":"Neurology"},{"key":"5836_CR84","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744\u2013748","journal-title":"Nature"},{"key":"5836_CR85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri2225","volume":"8","author":"S Goriely","year":"2008","unstructured":"Goriely S, Neurath MF, Goldman M (2008) How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 8:81\u201386","journal-title":"Nat Rev Immunol"},{"key":"5836_CR86","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1358\/dnp.2006.19.2.977443","volume":"19","author":"T Touil","year":"2006","unstructured":"Touil T, Fitzgerald D, Zhang GX, Rostami AM, Gran B (2006) Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis. Drug News Perspect 19:77\u201383","journal-title":"Drug News Perspect"},{"key":"5836_CR87","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archneur.63.6.858","volume":"63","author":"W Hu","year":"2006","unstructured":"Hu W, Dehmel T, Pirhonen J, Hartung HP, Kieseier BC (2006) Interleukin 23 in acute inflammatory demyelination of the peripheral nerve. Arch Neurol 63:858\u2013864","journal-title":"Arch Neurol"},{"key":"5836_CR88","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1189\/jlb.0609445","volume":"86","author":"H Yoshida","year":"2009","unstructured":"Yoshida H, Nakaya M, Miyazaki Y (2009) Interleukin 27: a double-edged sword for offense and defense. J Leukoc Biol 86:1295\u20131303","journal-title":"J Leukoc Biol"},{"key":"5836_CR89","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187152809787582507","volume":"8","author":"K Gee","year":"2009","unstructured":"Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A (2009) The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets 8:40\u201352","journal-title":"Inflamm Allergy Drug Targets"},{"key":"5836_CR90","first-page":"47","volume":"5","author":"PJ Armati","year":"1996","unstructured":"Armati PJ, Pollard JD (1996) Immunology of the Schwann cell. Baillieres Clin Neurol 5:47\u201364","journal-title":"Baillieres Clin Neurol"},{"key":"5836_CR91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(02)00003-6","volume":"124","author":"G Conti","year":"2002","unstructured":"Conti G, De Pol A, Scarpini E, Vaccina F, De Riz M, Baron P, Tiriticco M, Scarlato G (2002) Interleukin-1 beta and interferon-gamma induce proliferation and apoptosis in cultured Schwann cells. J Neuroimmunol 124:29\u201335","journal-title":"J Neuroimmunol"},{"key":"5836_CR92","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pain.2005.11.011","volume":"120","author":"G Wolf","year":"2006","unstructured":"Wolf G, Gabay E, Tal M, Yirmiya R, Shavit Y (2006) Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 120:315\u2013324","journal-title":"Pain"},{"key":"5836_CR93","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1254\/jphs.FP0072181","volume":"106","author":"R Hayashi","year":"2008","unstructured":"Hayashi R, Xiao W, Kawamoto M, Yuge O, Bennett GJ (2008) Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFalpha)-positive mast cells in rats with a painful peripheral neuropathy. J Pharmacol Sci 106:559\u2013565","journal-title":"J Pharmacol Sci"},{"key":"5836_CR94","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-510X(96)00319-X","volume":"147","author":"S Sivieri","year":"1997","unstructured":"Sivieri S, Ferrarini AM, Lolli F, Mata S, Pinto F, Tavolato B, Gallo P (1997) Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. J Neurol Sci 147:93\u201395","journal-title":"J Neurol Sci"},{"key":"5836_CR95","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","volume":"30","author":"HP Hartung","year":"1991","unstructured":"Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV (1991) Serum interleukin-2 concentrations in Guillain\u2013Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 30:48\u201353","journal-title":"Ann Neurol"},{"key":"5836_CR96","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tins.2005.06.008","volume":"28","author":"U Felderhoff-Mueser","year":"2005","unstructured":"Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF (2005) IL-18: a key player in neuroinflammation and neurodegeneration? Trends Neurosci 28:487\u2013493","journal-title":"Trends Neurosci"},{"key":"5836_CR97","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423\u2013474","journal-title":"Annu Rev Immunol"},{"key":"5836_CR98","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0165-5728(00)00460-4","volume":"114","author":"S Jander","year":"2001","unstructured":"Jander S, Stoll G (2001) Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy. J Neuroimmunol 114:253\u2013258","journal-title":"J Neuroimmunol"},{"key":"5836_CR99","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jneuroim.2006.12.001","volume":"183","author":"RS Duan","year":"2007","unstructured":"Duan RS, Zhang XM, Mix E, Quezada HC, Adem A, Zhu J (2007) IL-18 deficiency inhibits both Th1 and Th2 cytokine production but not the clinical symptoms in experimental autoimmune neuritis. J Neuroimmunol 183:162\u2013167","journal-title":"J Neuroimmunol"},{"key":"5836_CR100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0167-4889(02)00325-7","volume":"1592","author":"KJ Kallen","year":"2002","unstructured":"Kallen KJ (2002) The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochim Biophys Acta 1592:323\u2013343","journal-title":"Biochim Biophys Acta"},{"key":"5836_CR101","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1523\/JNEUROSCI.22-15-06696.2002","volume":"22","author":"GK Tofaris","year":"2002","unstructured":"Tofaris GK, Patterson PH, Jessen KR, Mirsky R (2002) Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 22:6696\u20136703","journal-title":"J Neurosci"},{"key":"5836_CR102","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0022-510X(94)90025-6","volume":"125","author":"J Zhu","year":"1994","unstructured":"Zhu J, Link H, Weerth S, Linington C, Mix E, Qiao J (1994) The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci 125:132\u2013137","journal-title":"J Neurol Sci"},{"key":"5836_CR103","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.4049\/jimmunol.179.4.2041","volume":"179","author":"S Dominitzki","year":"2007","unstructured":"Dominitzki S, Fantini MC, Neufert C, Nikolaev A, Galle PR, Scheller J, Monteleone G, Rose-John S, Neurath MF, Becker C (2007) Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J Immunol 179:2041\u20132045","journal-title":"J Immunol"},{"issue":"Suppl 3","key":"5836_CR104","doi-asserted-by":"crossref","first-page":"iii87","DOI":"10.1136\/ard.2007.078527","volume":"66","author":"M Oukka","year":"2007","unstructured":"Oukka M (2007) Interplay between pathogenic Th17 and regulatory T cells. Ann Rheum Dis 66(Suppl 3):iii87\u2013iii90","journal-title":"Ann Rheum Dis"},{"key":"5836_CR105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neulet.2008.03.050","volume":"437","author":"N Uceyler","year":"2008","unstructured":"Uceyler N, Sommer C (2008) Cytokine regulation in animal models of neuropathic pain and in human diseases. Neurosci Lett 437:194\u2013198","journal-title":"Neurosci Lett"},{"key":"5836_CR106","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(91)90313-V","volume":"104","author":"M Weller","year":"1991","unstructured":"Weller M, Stevens A, Sommer N, Melms A, Dichgans J, Wietholter H (1991) Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J Neurol Sci 104:215\u2013221","journal-title":"J Neurol Sci"},{"key":"5836_CR107","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1046\/j.1365-2567.1999.00808.x","volume":"97","author":"G Deretzi","year":"1999","unstructured":"Deretzi G, Pelidou SH, Zou LP, Quiding C, Zhu J (1999) Local effects of recombinant rat interleukin-6 on the peripheral nervous system. Immunology 97:582\u2013587","journal-title":"Immunology"},{"key":"5836_CR108","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/pho.2008.2266","volume":"26","author":"DS Choy","year":"2008","unstructured":"Choy DS, Black W, April R, Goldfinger G (2008) The Black\u2013Choy sign. Photomed Laser Surg 26:273","journal-title":"Photomed Laser Surg"},{"key":"5836_CR109","doi-asserted-by":"crossref","unstructured":"Nishimoto N, Kishimoto T (2008) Humanized antihuman IL-6 receptor antibody, tocilizumab. Handb Exp Pharmacol 181:151\u2013160","DOI":"10.1007\/978-3-540-73259-4_7"},{"key":"5836_CR110","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1517\/14728222.11.5.613","volume":"11","author":"S Rose-John","year":"2007","unstructured":"Rose-John S, Waetzig GH, Scheller J, Grotzinger J, Seegert D (2007) The IL-6\/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11:613\u2013624","journal-title":"Expert Opin Ther Targets"},{"key":"5836_CR111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1440-1789.2006.00651.x","volume":"26","author":"E Andriambeloson","year":"2006","unstructured":"Andriambeloson E, Baillet C, Vitte PA, Garotta G, Dreano M, Callizot N (2006) Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology 26:32\u201342","journal-title":"Neuropathology"},{"key":"5836_CR112","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2010.01.061","volume":"472","author":"T Ito","year":"2010","unstructured":"Ito T, Ikeda K, Tomita K, Yokoyama S (2010) Interleukin-6 upregulates the expression of PMP22 in cultured rat Schwann cells via a JAK2-dependent pathway. Neurosci Lett 472:104\u2013108","journal-title":"Neurosci Lett"},{"key":"5836_CR113","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuroscience.2008.01.014","volume":"152","author":"R Lara-Ramirez","year":"2008","unstructured":"Lara-Ramirez R, Segura-Anaya E, Martinez-Gomez A, Dent MA (2008) Expression of interleukin-6 receptor alpha in normal and injured rat sciatic nerve. Neuroscience 152:601\u2013608","journal-title":"Neuroscience"},{"key":"5836_CR114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.icb.7100113","volume":"86","author":"H Knupfer","year":"2008","unstructured":"Knupfer H, Preiss R (2008) sIL-6R: more than an agonist? Immunol Cell Biol 86:87\u201391","journal-title":"Immunol Cell Biol"},{"key":"5836_CR115","doi-asserted-by":"crossref","first-page":"979258","DOI":"10.1155\/2009\/979258","volume":"2009","author":"M Kunz","year":"2009","unstructured":"Kunz M, Ibrahim SM (2009) Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009:979258","journal-title":"Mediators Inflamm"},{"key":"5836_CR116","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2741\/2667","volume":"13","author":"JJ Yu","year":"2008","unstructured":"Yu JJ, Gaffen SL (2008) Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13:170\u2013177","journal-title":"Front Biosci"},{"key":"5836_CR117","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.4049\/jimmunol.0801967","volume":"182","author":"S Zrioual","year":"2009","unstructured":"Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis MA, Miossec P (2009) Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 182:3112\u20133120","journal-title":"J Immunol"},{"key":"5836_CR118","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.1741","volume":"10","author":"A Doreau","year":"2009","unstructured":"Doreau A, Belot A, Bastid J, Riche B, Trescol-Biemont MC, Ranchin B, Fabien N, Cochat P, Pouteil-Noble C, Trolliet P, Durieu I, Tebib J, Kassai B, Ansieau S, Puisieux A, Eliaou JF, Bonnefoy-Berard N (2009) Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat Immunol 10:778\u2013785","journal-title":"Nat Immunol"},{"key":"5836_CR119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00281-009-0186-z","volume":"32","author":"BM Segal","year":"2010","unstructured":"Segal BM (2010) Th17 cells in autoimmune demyelinating disease. Semin Immunopathol 32:71\u201377","journal-title":"Semin Immunopathol"},{"key":"5836_CR120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-3083.2007.02035.x","volume":"67","author":"WH Piao","year":"2008","unstructured":"Piao WH, Jee YH, Liu RL, Coons SW, Kala M, Collins M, Young DA, Campagnolo DI, Vollmer TL, Bai XF, La Cava A, Shi FD (2008) IL-21 modulates CD4+CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand J Immunol 67:37\u201346","journal-title":"Scand J Immunol"},{"key":"5836_CR121","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4049\/jimmunol.0802978","volume":"182","author":"R Spolski","year":"2009","unstructured":"Spolski R, Kim HP, Zhu W, Levy DE, Leonard WJ (2009) IL-21 mediates suppressive effects via its induction of IL-10. J Immunol 182:2859\u20132867","journal-title":"J Immunol"},{"key":"5836_CR122","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","volume":"134","author":"MO Li","year":"2008","unstructured":"Li MO, Flavell RA (2008) TGF-beta: a master of all T cell trades. Cell 134:392\u2013404","journal-title":"Cell"},{"key":"5836_CR123","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.immuni.2006.08.013","volume":"25","author":"DA Horwitz","year":"2006","unstructured":"Horwitz DA (2006) Transforming growth factor-beta: taking control of T cells\u2019 life and death. Immunity 25:399\u2013401","journal-title":"Immunity"},{"key":"5836_CR124","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","volume":"24","author":"MO Li","year":"2006","unstructured":"Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99\u2013146","journal-title":"Annu Rev Immunol"},{"key":"5836_CR125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cellimm.2007.10.006","volume":"249","author":"BG Xiao","year":"2007","unstructured":"Xiao BG, Zhu WH, Lu CZ (2007) The presence of GM-CSF and IL-4 interferes with effect of TGF-beta1 on antigen presenting cells in patients with multiple sclerosis and in rats with experimental autoimmune encephalomyelitis. Cell Immunol 249:30\u201336","journal-title":"Cell Immunol"},{"key":"5836_CR126","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1073\/pnas.0805058105","volume":"105","author":"Y Laouar","year":"2008","unstructured":"Laouar Y, Town T, Jeng D, Tran E, Wan Y, Kuchroo VK, Flavell RA (2008) TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105:10865\u201310870","journal-title":"Proc Natl Acad Sci USA"},{"key":"5836_CR127","first-page":"165","volume":"41","author":"LY Lu","year":"2008","unstructured":"Lu LY, Chu JJ, Lu PJ, Sung PK, Hsu CM, Tseng JC (2008) Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus. J Microbiol Immunol Infect 41:165\u2013173","journal-title":"J Microbiol Immunol Infect"},{"key":"5836_CR128","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ni1391","volume":"7","author":"M Veldhoen","year":"2006","unstructured":"Veldhoen M, Hocking RJ, Flavell RA, Stockinger B (2006) Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7:1151\u20131156","journal-title":"Nat Immunol"},{"key":"5836_CR129","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ni.1610","volume":"9","author":"N Manel","year":"2008","unstructured":"Manel N, Unutmaz D, Littman DR (2008) The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9:641\u2013649","journal-title":"Nat Immunol"},{"key":"5836_CR130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07021","volume":"454","author":"L Yang","year":"2008","unstructured":"Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA (2008) IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454:350\u2013352","journal-title":"Nature"},{"key":"5836_CR131","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jnnp.64.2.162","volume":"64","author":"A Creange","year":"1998","unstructured":"Creange A, Belec L, Clair B, Degos JD, Raphael JC, Gherardi RK (1998) Circulating transforming growth factor beta 1 (TGF-beta1) in Guillain\u2013Barre syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 64:162\u2013165","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5836_CR132","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1468-1331.2000.00005.x","volume":"7","author":"LM Ossege","year":"2000","unstructured":"Ossege LM, Sindern E, Voss B, Malin JP (2000) Expression of TNFalpha and TGFbeta1 in Guillain\u2013Barre syndrome: correlation of a low TNFalpha-\/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment. Eur J Neurol 7:17\u201325","journal-title":"Eur J Neurol"},{"key":"5836_CR133","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2249.1994.tb06142.x","volume":"98","author":"J Zhu","year":"1994","unstructured":"Zhu J, Mix E, Olsson T, Link H (1994) Cellular mRNA expression of interferon-gamma, IL-4 and transforming growth factor-beta (TGF-beta) by rat mononuclear cells stimulated with peripheral nerve myelin antigens in experimental allergic neuritis. Clin Exp Immunol 98:306\u2013312","journal-title":"Clin Exp Immunol"},{"key":"5836_CR134","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1600-0463.2003.apm1111204.x","volume":"111","author":"C Dahle","year":"2003","unstructured":"Dahle C, Kvarnstrom M, Ekerfelt C, Samuelsson M, Ernerudh J (2003) Elevated number of cells secreting transforming growth factor beta in Guillain\u2013Barre syndrome. APMIS 111:1095\u20131104","journal-title":"APMIS"},{"key":"5836_CR135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF00868524","volume":"243","author":"E Sindern","year":"1996","unstructured":"Sindern E, Schweppe K, Ossege LM, Malin JP (1996) Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain\u2013Barre syndrome. J Neurol 243:264\u2013268","journal-title":"J Neurol"},{"key":"5836_CR136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","volume":"223","author":"A O\u2019Garra","year":"2008","unstructured":"O\u2019Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C (2008) Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 223:114\u2013131","journal-title":"Immunol Rev"},{"key":"5836_CR137","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2009.05.012","volume":"31","author":"M Saraiva","year":"2009","unstructured":"Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, O\u2019Garra A (2009) Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31:209\u2013219","journal-title":"Immunity"},{"key":"5836_CR138","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1529-8027.2007.00148.x","volume":"12","author":"S Atkins","year":"2007","unstructured":"Atkins S, Loescher AR, Boissonade FM, Smith KG, Occleston N, O\u2019Kane S, Ferguson MW, Robinson PP (2007) Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repair. J Peripher Nerv Syst 12:269\u2013276","journal-title":"J Peripher Nerv Syst"},{"key":"5836_CR139","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2008.04.011","volume":"198","author":"ED Milligan","year":"2008","unstructured":"Milligan ED, Sloane EM, Watkins LR (2008) Glia in pathological pain: a role for fractalkine. J Neuroimmunol 198:113\u2013120","journal-title":"J Neuroimmunol"},{"key":"5836_CR140","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbi.2006.10.012","volume":"21","author":"A Ledeboer","year":"2007","unstructured":"Ledeboer A, Jekich BM, Sloane EM, Mahoney JH, Langer SJ, Milligan ED, Martin D, Maier SF, Johnson KW, Leinwand LA, Chavez RA, Watkins LR (2007) Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun 21:686\u2013698","journal-title":"Brain Behav Immun"},{"key":"5836_CR141","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1073\/pnas.0712131105","volume":"105","author":"JN Stern","year":"2008","unstructured":"Stern JN, Keskin DB, Zhang H, Lv H, Kato Z, Strominger JL (2008) Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice. Proc Natl Acad Sci USA 105:5172\u20135176","journal-title":"Proc Natl Acad Sci USA"},{"key":"5836_CR142","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-5728(03)00133-4","volume":"139","author":"KM Myhr","year":"2003","unstructured":"Myhr KM, Vagnes KS, Maroy TH, Aarseth JH, Nyland HI, Vedeler CA (2003) Interleukin-10 promoter polymorphisms in patients with Guillain\u2013Barre syndrome. J Neuroimmunol 139:81\u201383","journal-title":"J Neuroimmunol"},{"key":"5836_CR143","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2007.01.015","volume":"185","author":"W Yun","year":"2007","unstructured":"Yun W, Hua-bing W, Wei-zhi W (2007) A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats. J Neuroimmunol 185:87\u201394","journal-title":"J Neuroimmunol"},{"key":"5836_CR144","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-510X(97)00178-0","volume":"153","author":"C Dahle","year":"1997","unstructured":"Dahle C, Ekerfelt C, Vrethem M, Samuelsson M, Ernerudh J (1997) T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain\u2013Barre syndrome. J Neurol Sci 153:54\u201360","journal-title":"J Neurol Sci"},{"key":"5836_CR145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.iy.09.040191.003153","volume":"9","author":"JJ Oppenheim","year":"1991","unstructured":"Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene \u201cintercrine\u201d cytokine family. Annu Rev Immunol 9:617\u2013648","journal-title":"Annu Rev Immunol"},{"key":"5836_CR146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/1359-6101(96)00003-2","volume":"7","author":"RM Ransohoff","year":"1996","unstructured":"Ransohoff RM, Glabinski A, Tani M (1996) Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev 7:35\u201346","journal-title":"Cytokine Growth Factor Rev"},{"key":"5836_CR147","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"338","author":"AD Luster","year":"1998","unstructured":"Luster AD (1998) Chemokines\u2013chemotactic cytokines that mediate inflammation. N Engl J Med 338:436\u2013445","journal-title":"N Engl J Med"},{"key":"5836_CR148","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0165-5728(99)00100-9","volume":"98","author":"LP Zou","year":"1999","unstructured":"Zou LP, Pelidou SH, Abbas N, Deretzi G, Mix E, Schaltzbeerg M, Winblad B, Zhu J (1999) Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol 98:168\u2013175","journal-title":"J Neuroimmunol"},{"key":"5836_CR149","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0165-5728(02)00393-4","volume":"134","author":"D Orlikowski","year":"2003","unstructured":"Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphael JC, Gherardi RK, Creange A (2003) Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain\u2013Barre syndrome and experimental autoimmune neuritis. J Neuroimmunol 134:118\u2013127","journal-title":"J Neuroimmunol"},{"key":"5836_CR150","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","volume":"125","author":"BC Kieseier","year":"2002","unstructured":"Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP (2002) Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125:823\u2013834","journal-title":"Brain"},{"key":"5836_CR151","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13550289909029742","volume":"5","author":"T Fujioka","year":"1999","unstructured":"Fujioka T, Kolson DL, Rostami AM (1999) Chemokines and peripheral nerve demyelination. J Neurovirol 5:27\u201331","journal-title":"J Neurovirol"},{"key":"5836_CR152","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1024532715775","volume":"23","author":"R Press","year":"2003","unstructured":"Press R, Pashenkov M, Jin JP, Link H (2003) Aberrated levels of cerebrospinal fluid chemokines in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol 23:259\u2013267","journal-title":"J Clin Immunol"},{"key":"5836_CR153","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2008.04.019","volume":"437","author":"L Luongo","year":"2008","unstructured":"Luongo L, Sajic M, Grist J, Clark AK, Maione S, Malcangio M (2008) Spinal changes associated with mechanical hypersensitivity in a model of Guillain\u2013Barre syndrome. Neurosci Lett 437:98\u2013102","journal-title":"Neurosci Lett"},{"key":"5836_CR154","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI200112563","volume":"108","author":"T Chitnis","year":"2001","unstructured":"Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ (2001) Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 108:739\u2013747","journal-title":"J Clin Invest"},{"key":"5836_CR155","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1038\/sj.onc.1203485","volume":"19","author":"AL Wurster","year":"2000","unstructured":"Wurster AL, Tanaka T, Grusby MJ (2000) The biology of Stat4 and Stat6. Oncogene 19:2577\u20132584","journal-title":"Oncogene"},{"key":"5836_CR156","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/382174a0","volume":"382","author":"MH Kaplan","year":"1996","unstructured":"Kaplan MH, Sun YL, Hoey T, Grusby MJ (1996) Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382:174\u2013177","journal-title":"Nature"},{"key":"5836_CR157","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.molimm.2006.11.025","volume":"44","author":"LA O\u2019Sullivan","year":"2007","unstructured":"O\u2019Sullivan LA, Liongue C, Lewis RS, Stephenson SE, Ward AC (2007) Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol 44:2497\u20132506","journal-title":"Mol Immunol"},{"key":"5836_CR158","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/intimm\/dxh030","volume":"16","author":"M Fujimoto","year":"2004","unstructured":"Fujimoto M, Tsutsui H, Xinshou O, Tokumoto M, Watanabe D, Shima Y, Yoshimoto T, Hirakata H, Kawase I, Nakanishi K, Kishimoto T, Naka T (2004) Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int Immunol 16:303\u2013314","journal-title":"Int Immunol"},{"key":"5836_CR159","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI16156","volume":"111","author":"PJ Egan","year":"2003","unstructured":"Egan PJ, Lawlor KE, Alexander WS, Wicks IP (2003) Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 111:915\u2013924","journal-title":"J Clin Invest"},{"key":"5836_CR160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/14728222.12.2.171","volume":"12","author":"CJ Malemud","year":"2008","unstructured":"Malemud CJ, Miller AH (2008) Pro-inflammatory cytokine-induced SAPK\/MAPK and JAK\/STAT in rheumatoid arthritis and the new anti-depression drugs. Expert Opin Ther Targets 12:171\u2013183","journal-title":"Expert Opin Ther Targets"},{"key":"5836_CR161","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/08830180802295740","volume":"27","author":"JA Roman-Blas","year":"2008","unstructured":"Roman-Blas JA, Jimenez SA (2008) Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis. Int Rev Immunol 27:351\u2013374","journal-title":"Int Rev Immunol"},{"key":"5836_CR162","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2008.03.008","volume":"196","author":"K Mangano","year":"2008","unstructured":"Mangano K, Dati G, Quattrocchi C, Proietti L, Mazzarino C, Di Marco R, Bendtzen K, Greco B, Zaratin P, Nicoletti F (2008) Preventive and curative effects of cyclophosphamide in an animal model of Guillain\u2013Barre syndrome. J Neuroimmunol 196:107\u2013115","journal-title":"J Neuroimmunol"},{"key":"5836_CR163","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.4049\/jimmunol.0803851","volume":"183","author":"CF Brereton","year":"2009","unstructured":"Brereton CF, Sutton CE, Lalor SJ, Lavelle EC, Mills KH (2009) Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J Immunol 183:1715\u20131723","journal-title":"J Immunol"},{"key":"5836_CR164","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/187153009788452417","volume":"9","author":"T Wu","year":"2009","unstructured":"Wu T, Mohan C (2009) The AKT axis as a therapeutic target in autoimmune diseases. Endocr Metab Immune Disord Drug Targets 9:145\u2013150","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"5836_CR165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/156802606775270323","volume":"6","author":"C Peifer","year":"2006","unstructured":"Peifer C, Wagner G, Laufer S (2006) New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Curr Top Med Chem 6:113\u2013149","journal-title":"Curr Top Med Chem"},{"key":"5836_CR166","first-page":"515","volume":"9","author":"C Ding","year":"2008","unstructured":"Ding C, Xu J, Li J (2008) ABT-874, a fully human monoclonal anti-IL-12\/IL-23 antibody for the potential treatment of autoimmune diseases. Curr Opin Investig Drugs 9:515\u2013522","journal-title":"Curr Opin Investig Drugs"},{"key":"5836_CR167","first-page":"53","volume":"10","author":"A Billich","year":"2007","unstructured":"Billich A (2007) Drug evaluation: apilimod, an oral IL-12\/IL-23 inhibitor for the treatment of autoimmune diseases and common variable immunodeficiency. IDrugs 10:53\u201359","journal-title":"IDrugs"},{"key":"5836_CR168","first-page":"947","volume":"8","author":"BM Wittig","year":"2007","unstructured":"Wittig BM (2007) Drug evaluation: CNTO-1275, a mAb against IL-12\/IL-23p40 for the potential treatment of inflammatory diseases. Curr Opin Investig Drugs 8:947\u2013954","journal-title":"Curr Opin Investig Drugs"},{"key":"5836_CR169","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.290.5495.1354","volume":"290","author":"VP Badovinac","year":"2000","unstructured":"Badovinac VP, Tvinnereim AR, Harty JT (2000) Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. Science 290:1354\u20131358","journal-title":"Science"},{"key":"5836_CR170","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00007890-199907150-00023","volume":"68","author":"AT Hassan","year":"1999","unstructured":"Hassan AT, Dai Z, Konieczny BT, Ring GH, Baddoura FK, Abou-Dahab LH, El-Sayed AA, Lakkis FG (1999) Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-gamma: implications for long-term allograft acceptance. Transplantation 68:124\u2013129","journal-title":"Transplantation"},{"key":"5836_CR171","first-page":"277","volume":"7","author":"S Skurkovich","year":"2001","unstructured":"Skurkovich S, Boiko A, Beliaeva I, Buglak A, Alekseeva T, Smirnova N, Kulakova O, Tchechonin V, Gurova O, Deomina T, Favorova OO, Skurkovic B, Gusev E (2001) Randomized study of antibodies to IFN-gamma and TNF-alpha in secondary progressive multiple sclerosis. Mult Scler 7:277\u2013284","journal-title":"Mult Scler"},{"key":"5836_CR172","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1196\/annals.1398.020","volume":"1109","author":"B Skurkovich","year":"2007","unstructured":"Skurkovich B, Skurkovich S (2007) Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment. Ann N Y Acad Sci 1109:167\u2013177","journal-title":"Ann N Y Acad Sci"},{"key":"5836_CR173","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","volume":"76","author":"PA Csurhes","year":"2005","unstructured":"Csurhes PA, Sullivan AA, Green K, Pender MP, McCombe PA (2005) T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 76:1431\u20131439","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5836_CR174","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08916930008994078","volume":"32","author":"N Abbas","year":"2000","unstructured":"Abbas N, Zou LP, Pelidou SH, Winblad B, Zhu J (2000) Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system. Autoimmunity 32:93\u201399","journal-title":"Autoimmunity"},{"key":"5836_CR175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0028-3908(99)00144-6","volume":"39","author":"LP Zou","year":"2000","unstructured":"Zou LP, Deretzi G, Pelidou SH, Levi M, Wahren B, Quiding C, van der Meide P, Zhu J (2000) Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats. Neuropharmacology 39:324\u2013333","journal-title":"Neuropharmacology"},{"key":"5836_CR176","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0028-3908(02)00015-1","volume":"42","author":"LP Zou","year":"2002","unstructured":"Zou LP, Abbas N, Volkmann I, Nennesmo I, Levi M, Wahren B, Winblad B, Hedlund G, Zhu J (2002) Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1\/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue. Neuropharmacology 42:731\u2013739","journal-title":"Neuropharmacology"},{"key":"5836_CR177","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1007\/s00018-008-8521-4","volume":"65","author":"Z Zhang","year":"2008","unstructured":"Zhang Z, Zhang ZY, Fauser U, Schluesener HJ (2008) Valproic acid attenuates inflammation in experimental autoimmune neuritis. Cell Mol Life Sci 65:4055\u20134065","journal-title":"Cell Mol Life Sci"},{"key":"5836_CR178","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1582-4934.2008.00333.x","volume":"13","author":"ZY Zhang","year":"2009","unstructured":"Zhang ZY, Zhang Z, Fauser U, Schluesener HJ (2009) Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline. J Cell Mol Med 13:341\u2013351","journal-title":"J Cell Mol Med"},{"key":"5836_CR179","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.0901088","volume":"183","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Zhang ZY, Schluesener HJ (2009) Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J Immunol 183:3081\u20133091","journal-title":"J Immunol"},{"issue":"1","key":"5836_CR180","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.neuroscience.2010.04.074","volume":"169","author":"ZY Zhang","year":"2010","unstructured":"Zhang ZY, Zhang Z, Schluesener HJ (2010) MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis. Neuroscience 169(1):370\u2013377","journal-title":"Neuroscience"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5836-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5836-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T12:12:19Z","timestamp":1711973539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5836-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,23]]},"references-count":180,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["5836"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5836-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,23]]}}}